MSH2 and colorectal carcinoma: In the LS subgroup analysis of the CAPP2 study, MLH1 mutation and obesity was associated with a 3.72 times greater CRC risk (95% CI: 1.41 to 9.81), but no excess risk was observed in those with MSH2 or MSH6 mutation [48].